Cargando…

Pancreatic adenocarcinoma: insights into patterns of recurrence and disease behavior

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive cancers with high metastatic potential. Clinical observations suggest that there is disease heterogeneity among patients with different sites of distant metastases, yielding distinct clinical outcomes. Herein, we inves...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sahin, Ibrahim H., Elias, Harold, Chou, Joanne F., Capanu, Marinela, O’Reilly, Eileen M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064173/ https://www.ncbi.nlm.nih.gov/pubmed/30055578 http://dx.doi.org/10.1186/s12885-018-4679-9

Ejemplares similares

Pancreatic cancer stem cells may define tumor stroma characteristics and recurrence patterns in pancreatic ductal adenocarcinoma
por: Askan, Gokce, et al.
Publicado: (2021)

Circulating Tumor and Invasive Cell Gene Expression Profile Predicts Treatment Response and Survival in Pancreatic Adenocarcinoma
por: Yu, Kenneth H., et al.
Publicado: (2018)

Pancreatic cancer: Cutaneous metastases, clinical descriptors and outcomes
por: Gu, Lilly, et al.
Publicado: (2022)

Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of “Second Hit” in Germline BRCA1-Associated Pancreatic Ductal Adenocarcinoma
por: Zheng-Lin, Binbin, et al.
Publicado: (2022)

Does acute pancreatitis herald pancreatic ductal adenocarcinoma? A multicenter electronic health research network study
por: Singh, Ritu R., et al.
Publicado: (2022)

Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib
por: El Dika, Imane, et al.
Publicado: (2020)

Reducing nihilism in metastatic pancreatic ductal adenocarcinoma: Treatment, sequencing, and effects on survival outcomes
por: O'Reilly, Eileen M., et al.
Publicado: (2020)

Tumour response to TRK inhibition in a patient with pancreatic adenocarcinoma harbouring an NTRK gene fusion
por: O’Reilly, E M, et al.
Publicado: (2019)

CT features of HER2-mutant lung adenocarcinomas
por: Sawan, Peter, et al.
Publicado: (2018)

Prior irinotecan exposure does not preclude benefit to liposomal irinotecan in patients with metastatic pancreatic ductal adenocarcinoma
por: Yu, Kenneth H., et al.
Publicado: (2023)

Integrative analysis of functional genomic annotations and sequencing data to identify rare causal variants via hierarchical modeling
por: Capanu, Marinela, et al.
Publicado: (2015)

Neoadjuvant treatment of pancreatic adenocarcinoma: a systematic review and meta-analysis of 5520 patients
por: Dhir, Mashaal, et al.
Publicado: (2017)

Meta‐analysis of the impact of neoadjuvant therapy on patterns of recurrence in pancreatic ductal adenocarcinoma
por: Schorn, S., et al.
Publicado: (2018)

Genetic and clinical correlates of entosis in pancreatic ductal adenocarcinoma
por: Hayashi, Akimasa, et al.
Publicado: (2020)

A phase II study of gemcitabine and cisplatin plus sorafenib in patients with advanced biliary adenocarcinomas
por: Lee, J K, et al.
Publicado: (2013)

Pancreatic Cancer: BRCA Targeted Therapy and Beyond
por: Keane, Fergus, et al.
Publicado: (2023)

Duration of therapy for locally advanced pancreatic cancer: Does it matter?
por: Tuli, Richard, et al.
Publicado: (2020)

Outcomes and Molecular Features of Brain Metastasis in Gastroesophageal Adenocarcinoma
por: Tsai, Charlton, et al.
Publicado: (2022)

Editorial: Translational Insights Into Pancreatic Ductal Adenocarcinoma
por: Bijlsma, Maarten F., et al.
Publicado: (2022)

Neoadjuvant Treatment in Patients With Resectable and Borderline Resectable Pancreatic Cancer
por: Janssen, Quisette P., et al.
Publicado: (2020)

The tumor microenvironment of pancreatic adenocarcinoma and immune checkpoint inhibitor resistance: a perplex relationship
por: Sahin, Irem, et al.
Publicado: (2020)

Recurrence patterns of pancreatic cancer treated with adjuvant intensity modulated radiotherapy
por: Yıldırım, Halil Cumhur, et al.
Publicado: (2022)

Early and late recurrence patterns of pancreatic ductal adenocarcinoma after pancreaticoduodenectomy: a multicenter study
por: Zhang, Xiu-Ping, et al.
Publicado: (2023)

NF-κB and Pancreatic Cancer; Chapter and Verse
por: Silke, John, et al.
Publicado: (2021)

Recurrent noncoding regulatory mutations in pancreatic ductal adenocarcinoma
por: Feigin, Michael E., et al.
Publicado: (2017)

Comparative Recurrence Analysis of Pancreatic Adenocarcinoma after Resection
por: He, Chaobin, et al.
Publicado: (2021)

Preoperative Multiparametric Quantitative Magnetic Resonance Imaging Correlates with Prognosis and Recurrence Patterns in Pancreatic Ductal Adenocarcinoma
por: Qu, Chao, et al.
Publicado: (2022)

Comment On: Prospective Phase II Trials Validate the Effect of Neoadjuvant Chemotherapy on Pattern of Recurrence in Pancreatic Adenocarcinoma
por: Liu, Zhi-Peng, et al.
Publicado: (2023)

Acute and Chronic Pancreatic Inflammation
por: O'Reilly, Derek A., et al.
Publicado: (2012)

The pattern of recurrence of adenocarcinoma of the oesophago-gastric junction
por: Wayman, J, et al.
Publicado: (2002)

Resected pancreatic ductal adenocarcinomas with recurrence limited in lung have a significantly better prognosis than those with other recurrence patterns
por: Wangjam, Tamna, et al.
Publicado: (2015)

Identification of patients with pancreatic adenocarcinoma due to inheritable mutation: Challenges of daily clinical practice
por: Fulton, Alexander JP, et al.
Publicado: (2019)

Changing Practice Patterns and Improving Survival for Patients with Pancreatic Ductal Adenocarcinoma
por: Underwood, Patrick W., et al.
Publicado: (2023)

Identification of Rare Causal Variants in Sequence-Based Studies: Methods and Applications to VPS13B, a Gene Involved in Cohen Syndrome and Autism
por: Ionita-Laza, Iuliana, et al.
Publicado: (2014)

Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma
por: Tong, Yexin, et al.
Publicado: (2022)

The Clinical Course of Acute Pancreatitis and the Inflammatory Mediators That Drive It
por: Kylänpää, Leena, et al.
Publicado: (2012)

The effect of the low stromal ratio induced by neoadjuvant chemotherapy on recurrence patterns in borderline resectable pancreatic ductal adenocarcinoma
por: Kawahara, Kenji, et al.
Publicado: (2022)

A Guided Tutorial on Modelling Human Event-Related Potentials with Recurrent Neural Networks
por: O’Reilly, Jamie A., et al.
Publicado: (2022)

Perioperative versus total neoadjuvant chemotherapy in gastric cancer
por: Yang, Jessica, et al.
Publicado: (2023)

Prediction of early recurrence of pancreatic ductal adenocarcinoma after resection
por: Sugawara, Toshitaka, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8r4fe2amkiijaoogu49b804qtf